The Re-Appointment of M/s. Maheshwari Maheshwari & Co., Practicing Chartered Accountants (FRN: 105838W) as an Internal Auditor of the Company for the financial year 2025-26.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Globalspace Technologies' board, at its May 23, 2025 meeting, approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. Standalone revenue rose marginally to Rs 2,932.48 lakhs (FY24: Rs 2,904.80 lakhs), while net loss narrowed to Rs 183.71 lakhs (FY24: Rs 353.11 lakhs). Consolidated revenue grew sharply to Rs 4,304.58 lakhs driven by subsidiary Innopharma Healthcare (Rs 1,383.92 lakhs), though consolidated net loss stood at Rs 199.92 lakhs. The board also re-appointed Maheshwari Maheshwari & Co. (FRN: 105838W) as Internal Auditor for FY 2025-26 and granted 75,000 stock options to eligible employees under the 2018 ESOP scheme. Statutory auditor Bansilal Shah & Co. issued an unqualified opinion on the results.
For shareholders: The company continues to report losses at both standalone and consolidated levels, though the standalone loss has narrowed year-on-year. The fresh ESOP grant may cause marginal dilution. The internal auditor re-appointment is routine and not material to stock price.